Is nitrofurantoin (antibiotic) safe to use during the first trimester of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitrofurantoin Safety in First Trimester of Pregnancy

Nitrofurantoin can be used in the first trimester of pregnancy when no other suitable alternative antibiotics are available, but should not be considered first-line therapy due to mixed evidence regarding potential risks.

Current Guidelines on Nitrofurantoin Use in Pregnancy

  • The American College of Obstetricians and Gynecologists (ACOG) states that prescribing nitrofurantoin in the first trimester is appropriate when no other suitable alternative antibiotics are available 1.

  • According to Praxis Medical Insights, nitrofurantoin should be avoided in the third trimester due to risk of hemolytic anemia in the newborn, but can be used in pregnant women with normal renal function at a dose of 100 mg twice daily for 5-7 days 2.

  • First-line treatment for UTIs in pregnancy recommended by ACOG is cephalexin 500 mg every 6 hours for 7-14 days 2.

Evidence on Safety and Risks

Potential Risks

  • A 2015 meta-analysis found mixed results regarding nitrofurantoin safety in early pregnancy:

    • Cohort studies showed no increased risk of major malformations (RR 1.01,95% CI 0.81-1.26)
    • Case-control studies showed a slight but significant teratogenic risk (OR 1.22,95% CI 1.02-1.45)
    • Potential increased risk for hypoplastic left heart syndrome (OR 3.07,95% CI 1.59-5.93) 3
  • A 2018 CDC analysis noted potential risks for birth defects including anencephaly, heart defects, and orofacial clefts associated with nitrofurantoin use during pregnancy 4.

Clinical Approach

  1. First-line options for UTI in pregnancy:

    • Cephalexin 500 mg every 6 hours for 7-14 days
    • Cefixime 400 mg daily for 7-14 days
    • Amoxicillin with clavulanic acid 500 mg every 8 hours for 7-14 days 2
  2. When to consider nitrofurantoin in first trimester:

    • When first-line agents are contraindicated (e.g., severe allergy)
    • When pathogens are resistant to first-line agents
    • When no other suitable alternatives are available 1
  3. Nitrofurantoin dosing if needed:

    • 100 mg twice daily for 5-7 days (for patients with normal renal function) 2

Important Considerations and Precautions

  • Contraindications:

    • Renal impairment (GFR <30 ml/min)
    • Third trimester of pregnancy (risk of hemolytic anemia in newborn) 2
  • Monitoring:

    • Perform urine culture before starting treatment to confirm infection and antibiotic sensitivity 2
    • Monitor for rare but serious pulmonary reactions (fever, chills, cough, pleuritic chest pain, dyspnea) 5
  • Patient counseling:

    • Discuss the risks and benefits of treatment versus untreated UTI
    • Emphasize that untreated UTIs can lead to serious maternal and fetal complications 1

Decision Algorithm

  1. Confirm UTI diagnosis with urine culture
  2. Assess for contraindications to first-line agents (cephalosporins, amoxicillin-clavulanate)
  3. If first-line agents are appropriate → Use cephalexin or other first-line agent
  4. If first-line agents are contraindicated or ineffective → Consider nitrofurantoin if benefits outweigh risks
  5. If using nitrofurantoin, ensure:
    • Patient has normal renal function
    • Patient is not in third trimester
    • Shortest effective duration is prescribed
    • Patient is informed about potential risks and warning signs

Remember that untreated UTIs during pregnancy can lead to pyelonephritis, preterm labor, low birth weight, and sepsis, which pose significant risks to both mother and fetus 4. The decision to use nitrofurantoin must balance these risks against the potential risks of the medication.

References

Guideline

Urinary Tract Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Exposure to nitrofurantoin during early pregnancy and congenital malformations: a systematic review and meta-analysis.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.